- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 491/052 - Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
Patent holdings for IPC class C07D 491/052
Total number of patents in this class: 1085
10-year publication summary
95
|
74
|
78
|
78
|
81
|
77
|
103
|
103
|
85
|
42
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Gilead Sciences, Inc. | 2028 |
36 |
Bristol-myers Squibb Company | 4892 |
24 |
Merck Sharp & Dohme LLC | 3741 |
20 |
Merck Patent GmbH | 5850 |
17 |
Novartis AG | 10904 |
16 |
Eli Lilly and Company | 3814 |
15 |
F. Hoffmann-La Roche AG | 7926 |
14 |
Vertex Pharmaceuticals Incorporated | 1596 |
13 |
Daiichi Sankyo Company, Limited | 1852 |
13 |
Takeda Pharmaceutical Company Limited | 2704 |
12 |
Boehringer Ingelheim International GmbH | 4704 |
11 |
FUJIFILM Corporation | 29228 |
10 |
Arbutus Biopharma Corporation | 177 |
10 |
Genentech, Inc. | 3961 |
9 |
Merck Sharp & Dohme Corp. | 2201 |
9 |
Hoffmann-La Roche Inc. | 3379 |
8 |
The Regents of the University of California | 19812 |
8 |
Emory University | 1619 |
8 |
Kadmon Corporation, LLC | 94 |
8 |
Vanderbilt University | 1887 |
8 |
Other owners | 816 |